# The FINTEPLA as an Anti-SUDEP Therapy in Dravet Syndrome Project

> **NCT07112365** · PHASE4 · NOT_YET_RECRUITING · sponsor: **The University of Texas Health Science Center, Houston** · enrollment: 25 (estimated)

## Conditions studied

- Dravet Syndrome

## Interventions

- **DRUG:** Fenfluramine treatment (Fintepla)
- **DEVICE:** Hypercapnia Challenge using the device (RespirAct)

## Key facts

- **NCT ID:** NCT07112365
- **Lead sponsor:** The University of Texas Health Science Center, Houston
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04
- **Primary completion:** 2027-09-30
- **Final completion:** 2028-03-31
- **Target enrollment:** 25 (ESTIMATED)
- **Last updated:** 2026-04-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07112365

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07112365, "The FINTEPLA as an Anti-SUDEP Therapy in Dravet Syndrome Project". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07112365. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*